Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

25%

2 of 8 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

7(100.0%)

7Total

N/A(7)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT02852330Not ApplicableCompleted

Intracochlear Potentials: Volta Study

Role: collaborator

NCT03410017Completed

FLI Normative Study

Role: collaborator

NCT02746172Not ApplicableCompleted

Clinical Metrics for Assessing Cochlear Implant Recipient MAPs

Role: lead

NCT02879539Not ApplicableCompleted

Cochlear Implant Low Power Strategy

Role: lead

NCT02794623Not ApplicableCompleted

Tinnitus Suppression for Cochlear Implant Recipients

Role: lead

NCT02905305Not ApplicableCompleted

Cochlear Implant With Anti-Inflammatory Agent

Role: lead

NCT02984748Completed

Outcome Prediction in Cochlear Implant Recipients

Role: lead

NCT02765386Not ApplicableTerminated

Optimisation of Hybrid Fittings for Cochlear Implant Recipients

Role: lead

NCT02671032Not ApplicableCompleted

CHANGE Feasibility Study

Role: collaborator

All 9 trials loaded